Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,307 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by graham-pete, 10-24-2017, 12:52 PM
|
0 responses
1,150 views
0 reactions
|
Last Post
by graham-pete
10-24-2017, 12:52 PM
|
||
|
Started by Greeshma Thulasi, 10-20-2017, 11:34 PM
|
0 responses
1,099 views
0 reactions
|
Last Post
|
||
|
Started by PaigePenfold, 10-19-2017, 12:38 AM
|
0 responses
1,092 views
0 reactions
|
Last Post
by PaigePenfold
10-19-2017, 12:38 AM
|
||
|
Started by Penguin0123, 10-17-2017, 01:09 PM
|
0 responses
1,055 views
0 reactions
|
Last Post
by Penguin0123
10-17-2017, 01:09 PM
|
||
|
Started by John D, 10-15-2017, 06:22 AM
|
3 responses
1,375 views
0 reactions
|
Last Post
by seqtechno1
10-16-2017, 06:14 AM
|
||
|
Started by Misbah Abbas, 10-04-2017, 12:14 PM
|
0 responses
1,350 views
0 reactions
|
Last Post
by Misbah Abbas
10-04-2017, 12:14 PM
|
||
|
Started by glfrey, 10-02-2017, 12:25 AM
|
0 responses
1,041 views
0 reactions
|
Last Post
by glfrey
10-02-2017, 12:25 AM
|
||
|
Started by Guido72, 09-29-2017, 09:00 AM
|
0 responses
1,041 views
0 reactions
|
Last Post
by Guido72
09-29-2017, 09:00 AM
|
||
|
Started by sam08, 09-28-2017, 01:55 PM
|
0 responses
1,038 views
0 reactions
|
Last Post
by sam08
09-28-2017, 01:55 PM
|
||
|
Started by sharpo, 09-28-2017, 01:49 AM
|
0 responses
1,015 views
0 reactions
|
Last Post
by sharpo
09-28-2017, 01:49 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit in...-
Channel: Webinar Series
Today, 05:06 AM -
Recent Articles
Collapse
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 09-29-2026, 09:51 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
09-29-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 09-25-2026, 09:06 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
09-25-2026, 09:06 AM
|
||
|
Started by SEQadmin2, 09-23-2026, 11:05 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
09-23-2026, 11:05 AM
|